Sugi Predict

Sugi Predict / Compounds / SCHEMBL2802460

SCHEMBL2802460

SCHEMBL2802460

CN(C)CCCCNc1ncc2c(n1)-c1ccccc1C(c1ccc(NC(=O)Nc3ccc(F)cc3)cc1)C2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 10/20 0.39
▸ FGFR2 P21802 2/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ FGFR3 P22607 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ AXL P30530 2/20 0.37
▸ TYRO3 Q06418 2/20 0.37
▸ MERTK Q12866 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ NAMPT P43490 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ GBA1 P04062 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807926 0.93 CYP1A2 (0.46) FGFR1FGFR2CSF1RFGFR3CYP1A2
SCHEMBL2805255 0.91 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL2805009 0.91 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL2804236 0.90 FGFR1 (0.38) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL2805358 0.89 FGFR1 (0.42) FGFR1FGFR2EGFRCYP1A2TYRO3
SCHEMBL2803447 0.89 FGFR1 (0.39) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL2802594 0.89 FGFR1 (0.40) FGFR1FGFR2CSF1RFGFR3CYP1A2
SCHEMBL16360137 0.89 FGFR1 (0.40) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL2804284 0.89 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3EGFR
SCHEMBL16360136 0.89 CYP1A2 (0.39) FGFR1FGFR2CSF1RFGFR3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 — — EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 — — EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 — — US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 — — US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 — — US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 — — US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.